Alpha Cognition ACOG
NASDAQ ACOG
$9.50 +0.61 (+6.86%)
At close: Aug 20, 2026 · 4:00 PM EDT

Alpha Cognition (ACOG) Asset Utilization Ratio (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Asset Utilization Ratio of 0.16 for Q4 2025.

Alpha Cognition (ACOG) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Alpha Cognition's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.16 for Q4 2025.

  • In Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.16; the TTM figure through Dec 2025 stood at 0.16 (changed N/A YoY), while the FY2025 annual figure was 0.16, changed N/A from the prior year.
  • Asset Utilization Ratio for Q4 2025 stood at 0.16.
  • The five-year high for Asset Utilization Ratio was 0.16 in Q4 2025, with the low at 0.16 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.38
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.20
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.90
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.54
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.13
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.13
10 Alpha Cognition 209.03 Mn 167.59 Mn 5.70 Mn 0.19

Historic Data

Download Data
DateValue
Jun 30, 2026 0.19
Dec 31, 2025 0.16